Raymond M. Jordt - 25 Jan 2026 Form 4 Insider Report for Altimmune, Inc. (ALT)

Signature
/s/ Gregory Weaver, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
25 Jan 2026
Net transactions value
-$21,202
Form type
4
Filing time
27 Jan 2026, 07:10:05 UTC
Previous filing
05 Jan 2026
Next filing
29 Jan 2026

Sponsored

Quoteable Key Fact

"Raymond M. Jordt filed Form 4 for Altimmune, Inc. (ALT) on 27 Jan 2026."

Quick Takeaways

  • This page summarizes Raymond M. Jordt's Form 4 filing for Altimmune, Inc. (ALT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 27 Jan 2026, 07:10.

What Changed

  • Previous filing in this sequence was filed on 05 Jan 2026.
  • Current net transaction value: -$21,202.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jordt Raymond M Chief Business Officer 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG /s/ Gregory Weaver, as Attorney-in-Fact 27 Jan 2026 0001960780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Options Exercise $0 +14,600 +34% $0.000000 57,770 25 Jan 2026 Direct F1
transaction ALT Common Stock, par value $0.0001 Tax liability $21,202 -3,855 -6.7% $5.50 53,915 25 Jan 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Restricted Stock Units Options Exercise $0 -14,600 -33% $0.000000 29,200 25 Jan 2026 Common Stock, par value $0.0001 14,600 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
F2 Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
F3 The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.